ArticleTranslational oncology2020

Osimertinib regressed an EGFR-mutant lung-adenocarcinoma bone-metastasis mouse model and increased long-term survival.

Takashi Higuchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.